Getting Started with Microdosing Psilocybin

What Is Microdosing

Microdosing refers to the practice of taking a sub-perceptual dose of a psychedelic substance — a quantity small enough that it produces no hallucinations, no significant alteration of consciousness, and no impairment of normal daily function. In the context of psilocybin mushrooms, a microdose is typically one-tenth to one-twentieth of a psychoactive dose. If a full experience might involve 2–3.5 grams of dried mushroom material, a microdose typically falls in the range of 0.05 to 0.3 grams, depending on the individual's body chemistry, the potency of the material, and the intended effect.

The rationale behind microdosing is that very low doses of psilocybin may engage serotonin receptors, particularly the 5-HT2A receptor, in ways that modulate mood, cognition, and emotional flexibility without producing the dramatic perceptual effects of a full psychedelic experience. Proponents report improvements in focus, emotional stability, creativity, and social openness. Critics and researchers point out that these effects may partly reflect expectation and placebo responses, and controlled clinical trials have produced mixed results. The scientific community generally regards microdosing as a promising but not yet proven area of investigation, and users should approach it with appropriate caution and realistic expectations.

It is important to distinguish microdosing from both recreational use and from therapeutic macro-dose sessions. Microdosing is generally intended as a long-term practice integrated into daily or near-daily life, whereas a full psychedelic session is a distinct, planned event. The two approaches engage different aspects of the psilocybin pharmacology and are not interchangeable. People who use microdosing therapeutically often do so as a complement to therapy or lifestyle work, not as a standalone intervention. As with any practice involving scheduled substances, the legal status of psilocybin in your jurisdiction must be understood before proceeding.

Common Microdosing Protocols

The most widely known microdosing schedule is the Fadiman Protocol, developed by psychedelic researcher James Fadiman and described in his 2011 book "The Psychedelic Explorer's Guide." This protocol involves dosing one day, then taking two off days before dosing again, giving a repeating 1-day-on, 2-days-off cycle. The rationale is that the off days allow any acute effects to dissipate and prevent tolerance buildup while still maintaining a regular rhythm. Many people find this schedule easy to maintain alongside a working week and report that they can feel a carry-over effect on the day after dosing, often experienced as a calmer, more productive day.

The Stamets Protocol, associated with mycologist Paul Stamets, uses a 4-days-on, 3-days-off schedule, often combined with stacking compounds — particularly lion's mane mushroom (Hericium erinaceus) and niacin (vitamin B3). Stamets proposes that this combination may promote neuroplasticity more effectively than psilocybin alone, as lion's mane stimulates nerve growth factor (NGF) and niacin acts as a flushing agent that may improve delivery of active compounds to peripheral nerve tissue. This protocol is not validated by clinical trials but has generated significant community interest and some preliminary observational data.

A third common approach is the every-other-day protocol, which involves alternating dose and off days in a strict 1-on, 1-off pattern. This schedule produces higher cumulative exposure than the Fadiman protocol over a given period and may increase the risk of tolerance or cumulative fatigue. Some practitioners prefer it because of its rhythmic simplicity. A fourth approach used by some people is intuitive or as-needed dosing — taking a microdose only on days when a specific task demands enhanced focus or creativity. This ad hoc approach lacks the systematic feedback that structured protocols provide but appeals to those who want minimal intervention. Most guides recommend starting with the Fadiman protocol because it is the most researched and offers natural rest periods for comparison.

Finding Your Starting Dose

Determining a starting dose is highly individual. Mushroom potency varies significantly between species, between batches of the same species, and even within a single flush of fruit bodies. Psilocybe cubensis, the most commonly studied species in microdosing contexts, averages roughly 0.6% psilocybin by dry weight, but individual samples can range from 0.3% to over 1.0%. This variability means that a dose calibrated to one batch may produce very different effects from the same mass of a different batch. The only way to manage this variability reliably is to work with a consistent, well-homogenised supply — ideally material that has been finely powdered and thoroughly mixed before being weighed into individual doses.

A sensible starting strategy is to begin at the lowest end of the commonly cited range: 0.05 grams (50 mg) of dried mushroom material. On the first dose day, observe carefully for any perceptual changes, mood shifts, or increased heart rate. If a dose is truly sub-perceptual, a day of work, social interaction, and ordinary tasks should proceed entirely normally. Any noticeable sensory effect, boundary anxiety, or difficulty concentrating is a signal that the dose is too high. Adjust down by 0.025–0.05 grams and try again after the standard off-day period. Conversely, if after several weeks at the starting dose no subjective effect at all is detectable — not even a subtle lift in mood or slight increase in focus — a modest upward adjustment to 0.1 or 0.15 grams may be warranted. Most people find a comfortable range between 0.1 and 0.2 grams of dried material.

Precision measurement is essential at microdose quantities. A standard kitchen scale cannot weigh accurately below 1 gram. A jeweller's scale or milligram-capable precision scale — available for $20–$60 online — is necessary for consistent dosing. Weigh the same capsule or piece of material multiple times to verify scale accuracy, using a known calibration weight if available. Pre-packing a set of capsules from a homogenised powder batch allows you to prepare a consistent supply with minimum re-weighing. Store prepared doses in an airtight, lightproof container in a cool location to minimise degradation of psilocybin over time.

Tracking Your Experience

Systematic tracking is one of the most valuable practices associated with microdosing, both for the individual seeking to refine their approach and for the broader research community that is building observational datasets. Tracking does not need to be elaborate: a simple daily journal noting dose taken, time of administration, sleep quality the night before, energy levels through the day, mood (rated 1–10 or described qualitatively), focus and productivity, social interactions, and any adverse effects provides a rich dataset over weeks and months. Review this data at the end of each week to detect patterns — which days feel best, whether the day after dosing differs from the dose day itself, and whether effects diminish or shift over time.

Structured rating scales improve the objectivity of self-report. The PANAS (Positive and Negative Affect Schedule) is a standardised 20-item mood checklist used in academic research and freely available online; rating it daily takes under five minutes and allows comparison with published normative data. The PHQ-9 (Patient Health Questionnaire for depression) and GAD-7 (Generalised Anxiety Disorder scale) are widely used clinical screening tools that can be self-administered monthly to monitor any change in underlying symptoms. These are not diagnostic instruments when self-administered, but they provide a structured comparative baseline. Similarly, cognitive tests such as Trail Making Test A and B are freely available online and can track attention and processing speed over the course of a protocol period.

Taking breaks — at minimum, one week off for every four weeks of dosing — is widely recommended in the microdosing community and serves several purposes. First, breaks allow you to distinguish which experienced benefits are due to the dosing and which reflect natural variation or other lifestyle factors. Second, they allow the nervous system to reset from any accumulated tolerance or subtle overstimulation. Third, comparing your baseline state (during a break) against your dosing period state is one of the clearest ways to assess whether the practice is producing meaningful change. Some people discover during breaks that their mood and cognition are comparable to the dosing period, suggesting a strong placebo component. Others notice a clear regression during off weeks, which provides meaningful evidence that the microdose is having a pharmacological effect. Either outcome is useful information.

Frequently Asked Questions

What dose counts as a microdose?

A microdose is generally defined as a dose that is sub-perceptual — meaning it produces no hallucinations, no significant alteration of time perception, no impairment of social or cognitive function, and no noticeable change in sensory experience. In practical terms for psilocybin mushrooms, this typically falls between 0.05 and 0.3 grams of dried Psilocybe cubensis material. The precise threshold is individual: some people are more sensitive and find 0.1 grams perceptually noticeable, while others require 0.25 grams before noticing any effect at all. A useful rule of thumb is that a dose is a true microdose if you could attend a meeting, drive a car, or care for a child without anyone noticing anything unusual and without your own performance being impaired.

What is the Fadiman Protocol?

The Fadiman Protocol, developed by psychedelic researcher James Fadiman, is a structured microdosing schedule based on a repeating three-day cycle: Day 1 is a dose day; Days 2 and 3 are off days with no dose taken. The cycle then repeats. Fadiman designed the protocol to allow any acute sub-perceptual effects to resolve fully on the off days, preventing tolerance from building while still maintaining regular exposure. A standard protocol period runs four to eight weeks, followed by a rest period. During the protocol, Fadiman recommends keeping a detailed journal and paying attention to differences between the dose day, the day after (which many people report as particularly positive), and the rest day. His self-blinding citizen science project has collected thousands of reports based on this schedule.

What is the Stamets Protocol?

The Stamets Protocol refers to a microdosing schedule associated with mycologist Paul Stamets, involving four consecutive days of dosing followed by three days off. Stamets often recommends combining psilocybin-containing mushrooms with lion's mane mushroom (Hericium erinaceus, thought to stimulate nerve growth factor) and niacin (vitamin B3, proposed as a vasodilating carrier that improves distribution of active compounds). This combination is sometimes called the "Stamets Stack." The 4-on, 3-off schedule aligns conveniently with a standard working week. There are currently no published controlled clinical trials specifically testing the Stamets Protocol or stack, though Stamets has co-authored observational research using survey data, and anecdotal reports in the microdosing community are numerous.

What is the every-other-day protocol for microdosing?

The every-other-day protocol is exactly as it sounds: a microdose is taken on alternating days, with a rest day in between each dose day. This creates a regular 1-on, 1-off rhythm throughout the protocol period. Compared to the Fadiman Protocol's 1-on, 2-off schedule, the every-other-day approach delivers doses more frequently. Some people prefer this for its rhythmic simplicity and because the regular rest days feel like a natural pause. The increased frequency may, however, lead to faster tolerance development in some individuals, and some community members report accumulating fatigue or anxiety when using this schedule for extended periods. It is generally recommended only after someone has established their comfortable dose on a less frequent schedule.

How do I measure microdoses accurately?

Accurate measurement at microdose quantities — typically 0.05 to 0.3 grams — requires a precision scale capable of measuring to 0.01 grams (10 mg) or ideally 0.001 grams (1 mg). Standard kitchen scales are accurate only to 1 gram and are completely unsuitable for this purpose. Jeweller's scales and milligram scales are available online for $20–$60 and are adequate for most microdosing preparation. For maximum consistency, powder your dried mushroom material thoroughly in a clean coffee grinder, mix it completely, and then portion it into pre-weighed capsules. Weigh each capsule (empty capsule weight subtracted) to confirm fill accuracy. Store capsules in a dark, airtight container. Re-calibrate your scale regularly using a known calibration weight (often included with the scale) and never measure on an uneven surface.

What is the effects timeline for microdosing?

The timeline for experiencing effects from microdosing varies between individuals and between protocols. On a dose day, effects — if any are perceptible at the chosen dose — typically begin within 30–60 minutes of ingestion and may last three to five hours before gradually fading. Many people report the day after dosing (Day 2 of the Fadiman cycle) as feeling particularly clear, calm, and productive. Over the course of a multi-week protocol, reported benefits such as improved mood stability, reduced rumination, and increased creative thinking often emerge gradually over two to four weeks rather than immediately. Tracking using daily ratings is helpful for detecting these gradual shifts. Some individuals report peak benefit at around four to six weeks, after which benefits may stabilise or plateau, suggesting a rest period is appropriate.

Does tolerance build up with microdosing?

Psilocybin produces rapid tolerance: taking the same dose on consecutive days quickly leads to diminished effects, because 5-HT2A receptors are downregulated after activation. This is why all major microdosing protocols include scheduled off days. With the Fadiman Protocol's 1-on, 2-off schedule, most people find that tolerance does not accumulate meaningfully over the course of a month-long protocol. More frequent dosing schedules or extending protocols beyond the recommended four to eight weeks without a break may lead to tolerance, in which case effects become less noticeable despite the same dose. Taking a full week off (sometimes called a "washout") typically restores baseline sensitivity. Cross-tolerance with LSD and other classical psychedelics also exists, meaning recent use of other serotonergic psychedelics will reduce sensitivity to psilocybin.

Can I microdose while working a full-time job?

Many people who microdose do so specifically to support professional performance, and a properly calibrated sub-perceptual dose should not interfere with work. The key is confirming that your dose is truly sub-perceptual before relying on it during work hours. Start your protocol on a day off, observe carefully, and adjust as needed before your first dose-day workday. Work involving operating machinery, driving, patient care, or other safety-sensitive activities warrants extra caution. Jobs requiring fine motor precision or rapid decision-making in high-stakes environments should similarly be considered carefully. Some people prefer to dose in the evenings or on weekends only and assess carry-over mood effects on subsequent work days, avoiding any potential for perceptual interference during working hours. Discussing microdosing with an employer is generally inadvisable in most professional contexts given the substance's legal status.

When should I take breaks from microdosing?

Breaks are an important and underemphasised part of responsible microdosing practice. At minimum, a one-week break after every four weeks of dosing is widely recommended. Some practitioners take a two-week break for every six-week protocol period. Breaks serve multiple functions: they prevent tolerance accumulation, allow natural mood baselines to re-establish so progress can be assessed comparatively, and reduce the risk of psychological dependency on the practice. Additionally, you should pause immediately if you experience increasing anxiety, irritability, emotional blunting, sleep disruption, or cardiovascular discomfort at any point. These symptoms suggest the dose is too high or that the substance is not a good fit for your current physiological or psychological state. Re-starting after a two-week break at a lower dose is the appropriate response. Extended breaks of one to three months are reasonable after completing several protocol cycles.

What tracking app or method should I use for microdosing?

Several purpose-built apps exist for microdosing tracking, including Microdosify, Quantified Citizen (used in academic research), and the Synthesis app. These offer built-in mood rating scales, dose logging, and in some cases comparison to anonymised community data. General journaling apps such as Day One, Notion, or even a standard spreadsheet work equally well and may be preferred by those who want full control over their data privacy. The most important factor is consistency: the method matters less than the habit of recording each day at the same time. At minimum, log dose taken (or 0 if an off day), overall mood (1–10), energy level (1–10), sleep quality from the night before, and any notable observations. Reviewing these entries weekly reveals patterns that are invisible day-to-day and forms the foundation of an informed, self-directed practice.